Ligand validation:3URB

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3URB_IMD_A_901	57%	72%	0.134	0.908	0.21	0.84	-	-	2	0	100%	1
3UR2_IMD_A_900	82%	73%	0.103	0.959	0.22	0.8	-	-	1	0	100%	1
3URQ_IMD_A_904	35%	72%	0.205	0.893	0.21	0.86	-	-	0	0	100%	1
3URN_IMD_B_905	34%	72%	0.22	0.902	0.2	0.85	-	-	0	0	100%	1
3URA_IMD_A_1372	24%	72%	0.221	0.853	0.23	0.82	-	-	0	0	100%	1
6G1J_IMD_A_404	15%	55%	0.202	0.765	0.5	1.2	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.